EMA Restricts Fosfomycin Use Following Evidence Review EMA Restricts Fosfomycin Use Following Evidence Review

The EMA will restrict use of intravenous and oral formulations and suspend pediatric and intramuscular formulations of fosfomycin-based antibiotics.News Alerts
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news